 | • レポートコード：QYR2104Z1207 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、細胞生存率アッセイのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒト細胞、微生物細胞、動物細胞）、用途別市場規模（製薬・バイオテクノロジー企業、学術・研究機関、病院・診断研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・細胞生存率アッセイの市場動向 ・企業の競争状況、市場シェア ・細胞生存率アッセイの種類別市場規模（ヒト細胞、微生物細胞、動物細胞） ・細胞生存率アッセイの用途別市場規模（製薬・バイオテクノロジー企業、学術・研究機関、病院・診断研究所、その他） ・細胞生存率アッセイの北米市場規模2016-2027（アメリカ、カナダ） ・細胞生存率アッセイのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・細胞生存率アッセイのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・細胞生存率アッセイの中南米市場規模2016-2027（メキシコ、ブラジル） ・細胞生存率アッセイの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Merck、Bio-Rad、GE、Danaher、BD、PerkinElmer、Promega、Biotium、Abcam、Creative Bioarray、Biotek Instruments） ・結論 |
Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment with various stimuli. Moreover, cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.
Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market.
Market Analysis and Insights: Global Cell Viability Assays Market
The global Cell Viability Assays market size is projected to reach US$ 3416.6 million by 2026, from US$ 2457.8 million in 2019, at a CAGR of 4.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Viability Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Viability Assays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Viability Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Viability Assays market.
Global Cell Viability Assays Scope and Market Size
Cell Viability Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell Viability Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Human Cells
Microbial Cells
Animal Cells
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospital and Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Merck
Bio-Rad
GE
Danaher
BD
PerkinElmer
Promega
Biotium
GE
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Viability Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Human Cells
1.2.3 Microbial Cells
1.2.4 Animal Cells
1.3 Market by Application
1.3.1 Global Cell Viability Assays Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutes
1.3.4 Hospital and Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Viability Assays Market Perspective (2016-2027)
2.2 Cell Viability Assays Growth Trends by Regions
2.2.1 Cell Viability Assays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell Viability Assays Historic Market Share by Regions (2016-2021)
2.2.3 Cell Viability Assays Forecasted Market Size by Regions (2022-2027)
2.3 Cell Viability Assays Industry Dynamic
2.3.1 Cell Viability Assays Market Trends
2.3.2 Cell Viability Assays Market Drivers
2.3.3 Cell Viability Assays Market Challenges
2.3.4 Cell Viability Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Viability Assays Players by Revenue
3.1.1 Global Top Cell Viability Assays Players by Revenue (2016-2021)
3.1.2 Global Cell Viability Assays Revenue Market Share by Players (2016-2021)
3.2 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell Viability Assays Revenue
3.4 Global Cell Viability Assays Market Concentration Ratio
3.4.1 Global Cell Viability Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Viability Assays Revenue in 2020
3.5 Cell Viability Assays Key Players Head office and Area Served
3.6 Key Players Cell Viability Assays Product Solution and Service
3.7 Date of Enter into Cell Viability Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Viability Assays Breakdown Data by Type
4.1 Global Cell Viability Assays Historic Market Size by Type (2016-2021)
4.2 Global Cell Viability Assays Forecasted Market Size by Type (2022-2027)
5 Cell Viability Assays Breakdown Data by Application
5.1 Global Cell Viability Assays Historic Market Size by Application (2016-2021)
5.2 Global Cell Viability Assays Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cell Viability Assays Market Size (2016-2027)
6.2 North America Cell Viability Assays Market Size by Type
6.2.1 North America Cell Viability Assays Market Size by Type (2016-2021)
6.2.2 North America Cell Viability Assays Market Size by Type (2022-2027)
6.2.3 North America Cell Viability Assays Market Size by Type (2016-2027)
6.3 North America Cell Viability Assays Market Size by Application
6.3.1 North America Cell Viability Assays Market Size by Application (2016-2021)
6.3.2 North America Cell Viability Assays Market Size by Application (2022-2027)
6.3.3 North America Cell Viability Assays Market Size by Application (2016-2027)
6.4 North America Cell Viability Assays Market Size by Country
6.4.1 North America Cell Viability Assays Market Size by Country (2016-2021)
6.4.2 North America Cell Viability Assays Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cell Viability Assays Market Size (2016-2027)
7.2 Europe Cell Viability Assays Market Size by Type
7.2.1 Europe Cell Viability Assays Market Size by Type (2016-2021)
7.2.2 Europe Cell Viability Assays Market Size by Type (2022-2027)
7.2.3 Europe Cell Viability Assays Market Size by Type (2016-2027)
7.3 Europe Cell Viability Assays Market Size by Application
7.3.1 Europe Cell Viability Assays Market Size by Application (2016-2021)
7.3.2 Europe Cell Viability Assays Market Size by Application (2022-2027)
7.3.3 Europe Cell Viability Assays Market Size by Application (2016-2027)
7.4 Europe Cell Viability Assays Market Size by Country
7.4.1 Europe Cell Viability Assays Market Size by Country (2016-2021)
7.4.2 Europe Cell Viability Assays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cell Viability Assays Market Size (2016-2027)
8.2 Asia-Pacific Cell Viability Assays Market Size by Type
8.2.1 Asia-Pacific Cell Viability Assays Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell Viability Assays Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell Viability Assays Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell Viability Assays Market Size by Application
8.3.1 Asia-Pacific Cell Viability Assays Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell Viability Assays Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell Viability Assays Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell Viability Assays Market Size by Region
8.4.1 Asia-Pacific Cell Viability Assays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell Viability Assays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell Viability Assays Market Size (2016-2027)
9.2 Latin America Cell Viability Assays Market Size by Type
9.2.1 Latin America Cell Viability Assays Market Size by Type (2016-2021)
9.2.2 Latin America Cell Viability Assays Market Size by Type (2022-2027)
9.2.3 Latin America Cell Viability Assays Market Size by Type (2016-2027)
9.3 Latin America Cell Viability Assays Market Size by Application
9.3.1 Latin America Cell Viability Assays Market Size by Application (2016-2021)
9.3.2 Latin America Cell Viability Assays Market Size by Application (2022-2027)
9.3.3 Latin America Cell Viability Assays Market Size by Application (2016-2027)
9.4 Latin America Cell Viability Assays Market Size by Country
9.4.1 Latin America Cell Viability Assays Market Size by Country (2016-2021)
9.4.2 Latin America Cell Viability Assays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Viability Assays Market Size (2016-2027)
10.2 Middle East & Africa Cell Viability Assays Market Size by Type
10.2.1 Middle East & Africa Cell Viability Assays Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell Viability Assays Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell Viability Assays Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell Viability Assays Market Size by Application
10.3.1 Middle East & Africa Cell Viability Assays Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell Viability Assays Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell Viability Assays Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell Viability Assays Market Size by Country
10.4.1 Middle East & Africa Cell Viability Assays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell Viability Assays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Cell Viability Assays Introduction
11.2.4 Merck Revenue in Cell Viability Assays Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Cell Viability Assays Introduction
11.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2016-2021)
11.3.5 Bio-Rad Recent Development
11.4 GE
11.4.1 GE Company Details
11.4.2 GE Business Overview
11.4.3 GE Cell Viability Assays Introduction
11.4.4 GE Revenue in Cell Viability Assays Business (2016-2021)
11.4.5 GE Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Cell Viability Assays Introduction
11.5.4 Danaher Revenue in Cell Viability Assays Business (2016-2021)
11.5.5 Danaher Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Cell Viability Assays Introduction
11.6.4 BD Revenue in Cell Viability Assays Business (2016-2021)
11.6.5 BD Recent Development
11.7 PerkinElmer
11.7.1 PerkinElmer Company Details
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Cell Viability Assays Introduction
11.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2016-2021)
11.7.5 PerkinElmer Recent Development
11.8 Promega
11.8.1 Promega Company Details
11.8.2 Promega Business Overview
11.8.3 Promega Cell Viability Assays Introduction
11.8.4 Promega Revenue in Cell Viability Assays Business (2016-2021)
11.8.5 Promega Recent Development
11.9 Biotium
11.9.1 Biotium Company Details
11.9.2 Biotium Business Overview
11.9.3 Biotium Cell Viability Assays Introduction
11.9.4 Biotium Revenue in Cell Viability Assays Business (2016-2021)
11.9.5 Biotium Recent Development
11.10 Abcam
11.10.1 Abcam Company Details
11.10.2 Abcam Business Overview
11.10.3 Abcam Cell Viability Assays Introduction
11.10.4 Abcam Revenue in Cell Viability Assays Business (2016-2021)
11.10.5 Abcam Recent Development
11.11 Creative Bioarray
11.11.1 Creative Bioarray Company Details
11.11.2 Creative Bioarray Business Overview
11.11.3 Creative Bioarray Cell Viability Assays Introduction
11.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2016-2021)
11.11.5 Creative Bioarray Recent Development
11.12 Biotek Instruments
11.12.1 Biotek Instruments Company Details
11.12.2 Biotek Instruments Business Overview
11.12.3 Biotek Instruments Cell Viability Assays Introduction
11.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2016-2021)
11.12.5 Biotek Instruments Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Human Cells
Table 3. Key Players of Microbial Cells
Table 4. Key Players of Animal Cells
Table 5. Global Cell Viability Assays Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cell Viability Assays Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cell Viability Assays Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cell Viability Assays Market Share by Regions (2016-2021)
Table 9. Global Cell Viability Assays Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cell Viability Assays Market Share by Regions (2022-2027)
Table 11. Cell Viability Assays Market Trends
Table 12. Cell Viability Assays Market Drivers
Table 13. Cell Viability Assays Market Challenges
Table 14. Cell Viability Assays Market Restraints
Table 15. Global Cell Viability Assays Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cell Viability Assays Market Share by Players (2016-2021)
Table 17. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Viability Assays as of 2020)
Table 18. Ranking of Global Top Cell Viability Assays Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cell Viability Assays Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell Viability Assays Product Solution and Service
Table 22. Date of Enter into Cell Viability Assays Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell Viability Assays Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cell Viability Assays Revenue Market Share by Type (2016-2021)
Table 26. Global Cell Viability Assays Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cell Viability Assays Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cell Viability Assays Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cell Viability Assays Revenue Market Share by Application (2016-2021)
Table 30. Global Cell Viability Assays Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cell Viability Assays Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cell Viability Assays Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cell Viability Assays Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cell Viability Assays Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cell Viability Assays Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cell Viability Assays Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cell Viability Assays Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cell Viability Assays Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cell Viability Assays Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cell Viability Assays Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cell Viability Assays Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cell Viability Assays Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cell Viability Assays Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cell Viability Assays Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cell Viability Assays Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cell Viability Assays Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cell Viability Assays Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cell Viability Assays Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cell Viability Assays Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cell Viability Assays Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cell Viability Assays Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cell Viability Assays Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cell Viability Assays Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cell Viability Assays Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cell Viability Assays Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cell Viability Assays Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cell Viability Assays Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cell Viability Assays Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cell Viability Assays Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cell Viability Assays Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cell Viability Assays Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Cell Viability Assays Product
Table 65. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Cell Viability Assays Product
Table 70. Merck Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Bio-Rad Company Details
Table 73. Bio-Rad Business Overview
Table 74. Bio-Rad Cell Viability Assays Product
Table 75. Bio-Rad Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 76. Bio-Rad Recent Development
Table 77. GE Company Details
Table 78. GE Business Overview
Table 79. GE Cell Viability Assays Product
Table 80. GE Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 81. GE Recent Development
Table 82. Danaher Company Details
Table 83. Danaher Business Overview
Table 84. Danaher Cell Viability Assays Product
Table 85. Danaher Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. BD Company Details
Table 88. BD Business Overview
Table 89. BD Cell Viability Assays Product
Table 90. BD Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 91. BD Recent Development
Table 92. PerkinElmer Company Details
Table 93. PerkinElmer Business Overview
Table 94. PerkinElmer Cell Viability Assays Product
Table 95. PerkinElmer Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 96. PerkinElmer Recent Development
Table 97. Promega Company Details
Table 98. Promega Business Overview
Table 99. Promega Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 100. Promega Recent Development
Table 101. Biotium Company Details
Table 102. Biotium Business Overview
Table 103. Biotium Cell Viability Assays Product
Table 104. Biotium Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 105. Biotium Recent Development
Table 106. Abcam Company Details
Table 107. Abcam Business Overview
Table 108. Abcam Cell Viability Assays Product
Table 109. Abcam Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 110. Abcam Recent Development
Table 111. Creative Bioarray Company Details
Table 112. Creative Bioarray Business Overview
Table 113. Creative Bioarray Cell Viability Assays Product
Table 114. Creative Bioarray Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 115. Creative Bioarray Recent Development
Table 116. Biotek Instruments Company Details
Table 117. Biotek Instruments Business Overview
Table 118. Biotek Instruments Cell Viability Assays Product
Table 119. Biotek Instruments Revenue in Cell Viability Assays Business (2016-2021) & (US$ Million)
Table 120. Biotek Instruments Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Viability Assays Market Share by Type: 2020 VS 2027
Figure 2. Human Cells Features
Figure 3. Microbial Cells Features
Figure 4. Animal Cells Features
Figure 5. Global Cell Viability Assays Market Share by Application: 2020 VS 2027
Figure 6. Pharmaceutical and Biotechnology Companies Case Studies
Figure 7. Academic and Research Institutes Case Studies
Figure 8. Hospital and Diagnostic Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Viability Assays Report Years Considered
Figure 11. Global Cell Viability Assays Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cell Viability Assays Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cell Viability Assays Market Share by Regions: 2020 VS 2027
Figure 14. Global Cell Viability Assays Market Share by Regions (2022-2027)
Figure 15. Global Cell Viability Assays Market Share by Players in 2020
Figure 16. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Viability Assays as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2020
Figure 18. Global Cell Viability Assays Revenue Market Share by Type (2016-2021)
Figure 19. Global Cell Viability Assays Revenue Market Share by Type (2022-2027)
Figure 20. North America Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cell Viability Assays Market Share by Type (2016-2027)
Figure 22. North America Cell Viability Assays Market Share by Application (2016-2027)
Figure 23. North America Cell Viability Assays Market Share by Country (2016-2027)
Figure 24. United States Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cell Viability Assays Market Share by Type (2016-2027)
Figure 28. Europe Cell Viability Assays Market Share by Application (2016-2027)
Figure 29. Europe Cell Viability Assays Market Share by Country (2016-2027)
Figure 30. Germany Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cell Viability Assays Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cell Viability Assays Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cell Viability Assays Market Share by Region (2016-2027)
Figure 40. China Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cell Viability Assays Market Share by Type (2016-2027)
Figure 48. Latin America Cell Viability Assays Market Share by Application (2016-2027)
Figure 49. Latin America Cell Viability Assays Market Share by Country (2016-2027)
Figure 50. Mexico Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cell Viability Assays Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cell Viability Assays Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cell Viability Assays Market Share by Country (2016-2027)
Figure 56. Turkey Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cell Viability Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 61. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 62. GE Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 63. Danaher Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 64. BD Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 65. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 66. Promega Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 67. Biotium Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 68. Abcam Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 69. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 70. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の生細胞＆死細胞生存率アッセイキット市場規模・現状・予測（2021年-2027年） Live/Dead Cell Viability Assay Kit to evaluate cell viability and cell density.The Live-Dead Cell Viability Assay Kit is a quick and simple three-color assay to measure cell viability. Market Analysis and Insights: Global Live & Dead Cell Viability Assay Kit Market The global Live & Dead Cell Viabil…- 世界の微生物燃料電池（MFC）市場規模・現状・予測（2021年-2027年） Microbial Fuel Cell (MFC) is a bio-electrochemical system that produces electric current by using bacteria. MFC is essentially a device that converts chemical energy into electrical energy by using bacteria or microorganisms. MFC has gained attention due to its capability to produce electricity from…
- 世界の動物用幹細胞治療市場規模・現状・予測（2021年-2027年） Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three …
- 世界の上皮幹細胞市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Epithelial Stem Cells Market The global Epithelial Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…